Canopy Growth Co. (NASDAQ:CGC – Get Free Report) was the target of some unusual options trading activity on Thursday. Investors bought 41,923 call options on the company. This is an increase of approximately 44% compared to the typical volume of 29,147 call options.
Analysts Set New Price Targets
CGC has been the subject of a number of research analyst reports. Sanford C. Bernstein upped their price objective on shares of Canopy Growth to $5.00 and gave the company a “market perform” rating in a research report on Wednesday, January 31st. Piper Sandler cut their price objective on shares of Canopy Growth from $5.00 to $3.00 and set an “underperform” rating for the company in a research report on Monday, February 12th.
Get Our Latest Stock Analysis on Canopy Growth
Canopy Growth Price Performance
Canopy Growth (NASDAQ:CGC – Get Free Report) last posted its quarterly earnings data on Friday, February 9th. The company reported ($1.79) earnings per share for the quarter, missing the consensus estimate of ($0.45) by ($1.34). The firm had revenue of $57.67 million for the quarter, compared to analyst estimates of $53.25 million. Canopy Growth had a negative return on equity of 73.48% and a negative net margin of 326.75%. As a group, equities analysts forecast that Canopy Growth will post -6.14 EPS for the current fiscal year.
Institutional Trading of Canopy Growth
Several hedge funds have recently modified their holdings of CGC. Lord Abbett & CO. LLC acquired a new stake in shares of Canopy Growth during the third quarter worth approximately $18,140,000. Vanguard Group Inc. grew its stake in shares of Canopy Growth by 26.3% during the third quarter. Vanguard Group Inc. now owns 10,233,037 shares of the company’s stock valued at $27,936,000 after purchasing an additional 2,133,358 shares during the last quarter. Two Sigma Advisers LP grew its stake in shares of Canopy Growth by 148.4% during the third quarter. Two Sigma Advisers LP now owns 2,874,400 shares of the company’s stock valued at $7,847,000 after purchasing an additional 1,717,300 shares during the last quarter. HRT Financial LP grew its stake in shares of Canopy Growth by 2,989.7% during the first quarter. HRT Financial LP now owns 1,036,372 shares of the company’s stock valued at $1,813,000 after purchasing an additional 1,002,829 shares during the last quarter. Finally, Goldman Sachs Group Inc. grew its stake in shares of Canopy Growth by 65.4% during the second quarter. Goldman Sachs Group Inc. now owns 1,687,125 shares of the company’s stock valued at $654,000 after purchasing an additional 666,800 shares during the last quarter. Institutional investors and hedge funds own 3.33% of the company’s stock.
Canopy Growth Company Profile
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products.
See Also
- Five stocks we like better than Canopy Growth
- Are Penny Stocks a Good Fit for Your Portfolio?
- Comprehensive PepsiCo Stock Analysis
- Best Aerospace Stocks Investing
- CSX Co.: The Railroad Powering Ahead with an Earnings Beat
- Canada Bond Market Holiday: How to Invest and Trade
- 3 Steel Stocks Could Soar on New China Tariffs
Receive News & Ratings for Canopy Growth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Canopy Growth and related companies with MarketBeat.com's FREE daily email newsletter.